美国儿科微生物实验室气管吸出物培养实践差异调查
该研究于2020年1月22日至2月24日对美国153家含儿科机构的医院微生物实验室人员进行了网络调查,应答率48%(73/153)。结果显示气管吸出物培养在标本接收、革兰染色和培养报告标准上存在高度中心间差异,非学术医院实验室和纯儿科实验室更倾向于鉴定、报告并进行药敏试验,不论菌量或优势菌。
要点
- 气管吸出物培养各流程标准差异大,缺乏统一实验室指南
- 77%实验室不依据革兰染色标准拒收标本
- 非学术和纯儿科实验室更常报告并做药敏,不论菌量
核心结论
- 儿科微生物实验室间气管吸出物培养流程存在大量变异,影响报告与治疗决策,并妨碍临床结局研究的解读。
研究设计与样本
- 2020年1月22日至2月24日对美国自由 standing 儿科医院及含儿科设施的成人医院微生物实验室人员进行的全国性网络调查,应答率48%(73/153)。
主要发现
- 所有流程(标本接收、革兰染色、培养报告)的标准均存在高度变异。
- 77%受访者不依据革兰染色标准拒收气管吸出物标本,44%实验室不要求报告前审查最低数量革兰染色视野。
- 非学术医院实验室和纯儿科实验室更倾向于鉴定、报告并进行药敏试验,不论菌量或优势菌。
临床怎么用
- 临床应意识到不同实验室气管吸出物培养报告标准差异大,解读结果需结合本地实验室流程。
- 实验室可参考本研究识别自身实践变异,为制定统一指南提供依据。
局限性
- 调查应答率48%,可能存在无应答偏倚。
- 研究仅描述实践变异,未评估患者临床结局。
- 调查时间为2020年,结果可能随时间变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the absence of evidence-based laboratory guidelines, the workup and interpretation of tracheal aspirate (TA) cultures remains controversial and confusing within the fields of clinical microbiology, infectious diseases, and critical care. Between 22 January and 24 February 2020, we conducted a national, web-based survey of microbiology laboratory personnel in free-standing pediatric hospitals and adult hospitals containing pediatric facilities regarding the laboratory practices used for TA specimens. We hypothesized there would be substantial center-level variability in laboratory processing of TA cultures. The response rate for the survey was 48% (73/153). There was a high level of variability in the criteria used for all processes, including specimen receipt, Gram staining, and culture reporting. Most respondents (77%) reported they do not reject TA specimens based on Gram stain criteria, and 44% of labs do not require that a minimum number of Gram stain fields be reviewed prior to reporting results. Overall, nonacademic hospital laboratories and pediatric-only laboratories are more likely to identify, report, and perform susceptibility testing on organisms from TA cultures, regardless of organism quantity or predominance. There is a substantial amount of process variability among pediatric microbiology laboratories that affects TA culture reporting, and which guides treatment decisions. This variation within and among labs makes clinical outcome studies related to TA cultures difficult to interpret. This study serves as a pragmatic step in informing the development of robust clinical guidelines. Clinical outcome and implementation studies are necessary to determine the effectiveness of guidelines for TA cultures.
引用
- Prinzi AM, Parker SK, Curtis DJ, et al. The Pediatric Endotracheal Aspirate Culture Survey (PETACS): Examining Practice Variation across Pediatric Microbiology Laboratories in the United States. J Clin Microbiol. 2021. PMID: 33298605. doi:10.1128/JCM.02232-20
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。